The answer to which treatment is better is still largely up in the air, according to a new study.
The research found that patients who received MS treatments experienced better outcomes than those who did not.
However, those who received surgery did not receive the same benefits as those who continued to receive MS treatment.
The study also found that people who received the most treatments had the lowest risk of developing MS in their later years.
“Our findings suggest that MS treatment should be considered in patients with active, ongoing clinical signs of MS, even if they are at a low risk of further progression,” the researchers said.
MS treatments are used to treat MS patients who have no further symptoms, but who have persistent symptoms of the disease.